Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Oral minoxidil rarely causes pericardial effusion, especially at low doses.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Compression therapy improved ankle movement, reduced leg swelling, and lessened pain in patients with venous leg ulcers.

Pranlukast and mirabegron may work as new diabetes drugs.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Finasteride and testosterone are the drugs most linked to male infertility, but many other potential drugs may be under-reported.

People were generally happy with the home light therapy devices for hair loss.

Certain drugs, especially those for eyes, bacterial infections, imaging tests, and skin conditions, are more likely to cause itching, with differences seen across gender, age, and weight.

Minoxidil solution and foam both increase hair growth, but the solution works better than the foam.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Aminoacridine and Minoxidil together show promise for better hair and nail growth.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.